REVLIMID is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, ...
The first test should be performed within 10-14 days and the second test within 24 hours prior to prescribing REVLIMID therapy and then weekly during the first ...
REVLIMID is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment ...
REVLIMID® (lenalidomide) in combination with dexamethasone (dex) is indicated for the treatment of adult patients with multiple myeloma (MM).
You must read the package leaflet of all medicinal products to be taken in combination with Revlimid before starting treament with Revlimid. Do not take ...
Revlimid is taken on certain days over 3 weeks (21 days). Every 21 days is called a 'treatment cycle'.
Missing: insert | Show results with:insert
Read this carefully before you start taking REVLIMID and each time you get a refill. This leaflet is a summary and will not tell you everything about this drug.
Revlimid® (lenalidomide), an oral medication, can be used throughout the myeloma disease course. Learn about side effects, support, and clinical trials.
EMPLICITI (elotuzumab) is indicated in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma.
Revlimid is a medicine used for the treatment of certain cancers and serious conditions affecting blood cells and bone marrow.
